ClinicalTrials.gg
Drug

Follicle Stimulating Hormone clinical trials

Also written FSH.

studies test it
23
open now
3
in phase 3
8
first study started
2000

Counted the way a researcher would: Follicle Stimulating Hormone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Follicle Stimulating Hormone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Follicle Stimulating Hormone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Sept 1997 · GONAL-F · BLA 020378 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Follicle Stimulating Hormone
6
FSH-GEX™
2
Gonal-F
2

Other names

FSH
5
follitropin epsilon
3

Studies by the year they started

23 studies that test it; most in 2011 (3)

Studies that test Follicle Stimulating Hormone, by start year
YearStudies
20001
20031
20071
20081
20101
20113
20133
20142
20152
20172
20202
20242
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
3
Phase 2
1
Phase 3
8
Phase 4
5
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 17

Glycotope GmbH (3) · IBSA Institut Biochimique SA (2) · Cairo University (2) · Hospital de Cruces (1) · ART Fertility Clinics LLC (1) · Istanbul University (1) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1) · Yale University (1)

Often tested with

Tested in the same studies.

Letrozole (3) · Clomiphene (2) · Antioxidants (1) · Luteinizing Hormone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Follicle Stimulating Hormone.

Studies

Open first, then newest update. How each study uses Follicle Stimulating Hormone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test Follicle Stimulating Hormone →

Given beside what is tested · 3 — Follicle Stimulating Hormone is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Follicle Stimulating Hormone

What changed recently

From the registry's own updates since Oct 18, 2026.

Stopped2

Codes

What other systems call Follicle Stimulating Hormone · ClinicalTrials.gg INT007526

  • MeSH (NLM) D005640Follicle Stimulating HormoneOne source ClinicalTrials.gov
  • RxNorm 227518One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.